Nifuratel

Nifuratel

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	G01AX05 (WHO)
Identifiers
IUPAC name 5-[(Methylthio)methyl]-3-{[(1E)-(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one
CAS Number	4936-47-4 Y
PubChem CID	6433427
ChemSpider	4938579
UNII	U60U6P08SP
KEGG	D01050 Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C10H11N3O5S
Molar mass	285.28 g/mol
3D model (JSmol)	Interactive image
SMILES CSCC1CN(C(=O)O1)/N=C/C2=CC=C(O2)[N+](=O)[O-]
InChI InChI=1S/C10H11N3O5S/c1-19-6-8-5-12(10(14)18-8)11-4-7-2-3-9(17-7)13(15)16/h2-4,8H,5-6H2,1H3/b11-4+ Key:SRQKTCXJCCHINN-NYYWCZLTSA-N
(verify)

WikiDoc Resources for Nifuratel
Articles
Most recent articles on Nifuratel Most cited articles on Nifuratel Review articles on Nifuratel Articles on Nifuratel in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Nifuratel Images of Nifuratel Photos of Nifuratel Podcasts & MP3s on Nifuratel Videos on Nifuratel
Evidence Based Medicine
Cochrane Collaboration on Nifuratel Bandolier on Nifuratel TRIP on Nifuratel
Clinical Trials
Ongoing Trials on Nifuratel at Clinical Trials.gov Trial results on Nifuratel Clinical Trials on Nifuratel at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Nifuratel NICE Guidance on Nifuratel NHS PRODIGY Guidance FDA on Nifuratel CDC on Nifuratel
Books
Books on Nifuratel
News
Nifuratel in the news Be alerted to news on Nifuratel News trends on Nifuratel
Commentary
Blogs on Nifuratel
Definitions
Definitions of Nifuratel
Patient Resources / Community
Patient resources on Nifuratel Discussion groups on Nifuratel Patient Handouts on Nifuratel Directions to Hospitals Treating Nifuratel Risk calculators and risk factors for Nifuratel
Healthcare Provider Resources
Symptoms of Nifuratel Causes & Risk Factors for Nifuratel Diagnostic studies for Nifuratel Treatment of Nifuratel
Continuing Medical Education (CME)
CME Programs on Nifuratel
International
Nifuratel en Espanol Nifuratel en Francais
Business
Nifuratel in the Marketplace Patents on Nifuratel
Experimental / Informatics
List of terms related to Nifuratel

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Nifuratel (brand name Macmiror, or—in combination with nystatin—Macmiror Complex) is a drug used in gynecology. It is a local antiprotozoal and antifungal agent that may also be given orally. Nifuratel is not approved for use in the United States.

Nifuratel appears to have a broad antibacterial spectrum of action and is effective against Chlamydia trachomatis and Mycoplasma spp. as well as fungal infections from Candida spp.

Taken orally, or as a vaginal pessary, it is used in the treatment of a wide range of infections of the genito-urinary tract, especially if there is no accurate diagnosis available. For example it may be used in the treatment of women exhibiting vaginal discharge where there is uncertainty as to whether the cause is Trichomonas vaginalis or Candida strains such as Candida albicans.

Side effects appear to be minimal or non-existent and it has a safe toxicological profile.